The forecasted trend of neoplasms mortality in Canada for females reveals a steady decline from 2024 to 2028, moving from 164.4 to 155.7 deaths per 100,000 women. Compared to the 2023 figures, which stood at 167.5, there is a clear downward trajectory. Between 2024 and 2025, there's a 1.4% decrease, followed by a 1.3% drop from 2025 to 2026. Continuing, a 1.4% decline is seen from 2026 to 2027, and from 2027 to 2028, there is again a 1.3% reduction. The five-year CAGR reflects an average annual decrease of approximately 1.5%.
Future trends to watch include advancements in medical research and treatment options, policy changes to enhance healthcare access, and potential socioeconomic factors that may impact health outcomes on a broad scale. Additionally, developments in preventive measures and early detection technologies could further accelerate the decline in mortality rates.
